CCL18 from tumor‐cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway
Cited by 69
Related Papers
PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming
|International Journal of Oncology|2020|21
Immunodiagnosis — the promise of personalized immunotherapy
|Frontiers in Immunology|2023|6